Empagliflozin Tablets 25 mg (EMPAGIL-25)
Product Description:
EMPAGIL-25 is a prescription medication containing Empagliflozin 25 mg, an SGLT2 (Sodium-Glucose Co-Transporter 2) inhibitor, used for the effective management of Type 2 Diabetes Mellitus. This medication works by reducing the reabsorption of glucose from the kidneys into the bloodstream, which helps to lower blood glucose levels by promoting the excretion of excess glucose through the urine. EMPAGIL-25 is designed to help achieve better glycemic control and offers additional benefits, such as weight management and cardiovascular protection.
Key Ingredient:
- Empagliflozin (25 mg): Empagliflozin is a potent SGLT2 inhibitor that helps control blood sugar levels by preventing glucose reabsorption in the kidneys, increasing glucose excretion in the urine, and thus lowering blood sugar levels in patients with Type 2 diabetes.
Indications: EMPAGIL-25 is prescribed as part of a comprehensive treatment plan that includes diet and exercise, to manage Type 2 Diabetes Mellitus in adults. It can be used alone or in combination with other antidiabetic drugs, such as Metformin or Insulin, to help maintain optimal blood sugar levels.
Benefits:
- Improved Glycemic Control: By reducing glucose reabsorption in the kidneys, EMPAGIL-25 helps lower blood sugar levels, providing better control over diabetes.
- Weight Loss: Empagliflozin promotes weight loss due to its ability to remove excess glucose from the body through urine, which may benefit many patients with Type 2 Diabetes.
- Cardiovascular Benefits: Empagliflozin has been shown to reduce the risk of major cardiovascular events, such as heart attack, stroke, and hospitalization for heart failure in patients with Type 2 diabetes and established heart disease.
- Kidney Protection: EMPAGIL-25 provides benefits for kidney health, especially in people with diabetic kidney disease, by slowing down the progression of kidney damage.
Usage Instructions: Take one 25 mg tablet of EMPAGIL-25 once daily, preferably in the morning, with or without food. The tablet should be swallowed whole with water. Follow your doctor’s instructions on dosage, and do not take more than the prescribed amount.
Precautions:
- Kidney Function: EMPAGIL-25 should not be used in patients with severe kidney impairment. Regular monitoring of kidney function is essential during treatment.
- Dehydration Risk: Due to its diuretic effect, Empagliflozin can cause dehydration, which can lead to low blood pressure and electrolyte imbalances. Ensure adequate fluid intake during treatment.
- Lactic Acidosis: Although rare, a serious condition called lactic acidosis can occur with medications like Empagliflozin, particularly in patients with impaired kidney function. Seek immediate medical attention if you experience symptoms such as muscle pain, weakness, fatigue, or difficulty breathing.
- Pregnancy and Lactation: EMPAGIL-25 should be used with caution during pregnancy and breastfeeding. Consult your doctor before using it during these periods.
Side Effects: Common side effects may include:
- Increased urination
- Urinary tract infections (UTIs)
- Genital fungal infections
- Thirst and dehydration
Serious side effects (though rare) can include:
- Lactic acidosis
- Kidney issues
- Severe allergic reactions (rash, swelling, difficulty breathing)
Storage: Store EMPAGIL-25 at room temperature (15-30°C) in a dry place, away from moisture and heat. Keep it in its original packaging and out of reach of children.
Packaging: EMPAGIL-25 is available in blister packs, making it convenient and easy to carry.
Conclusion: EMPAGIL-25 is an effective and convenient treatment for managing Type 2 Diabetes Mellitus, with benefits extending beyond blood glucose control, including weight management and cardiovascular protection. Always consult your healthcare provider to determine if EMPAGIL-25 is the right medication for your specific condition and follow the prescribed dosage carefully for optimal results.